SMT201500086B - Uso del nifuratel per il trattamento di infezioni causate dalla specie atopobium - Google Patents

Uso del nifuratel per il trattamento di infezioni causate dalla specie atopobium

Info

Publication number
SMT201500086B
SMT201500086B SM201500086T SM201500086T SMT201500086B SM T201500086 B SMT201500086 B SM T201500086B SM 201500086 T SM201500086 T SM 201500086T SM 201500086 T SM201500086 T SM 201500086T SM T201500086 B SMT201500086 B SM T201500086B
Authority
SM
San Marino
Prior art keywords
nifuratel
treatment
infections caused
atopobium species
atopobium
Prior art date
Application number
SM201500086T
Other languages
English (en)
Italian (it)
Inventor
Federico Mailland
Original Assignee
Polichem Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40935525&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SMT201500086(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Polichem Sa filed Critical Polichem Sa
Publication of SMT201500086B publication Critical patent/SMT201500086B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Dermatology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
SM201500086T 2009-04-20 2015-04-09 Uso del nifuratel per il trattamento di infezioni causate dalla specie atopobium SMT201500086B (it)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP09158221A EP2243482A1 (en) 2009-04-20 2009-04-20 Use of nifuratel to treat infections caused by atopobium species
PCT/EP2010/055090 WO2010121980A1 (en) 2009-04-20 2010-04-19 Use of nifuratel to treat infections caused by atopobium species

Publications (1)

Publication Number Publication Date
SMT201500086B true SMT201500086B (it) 2015-05-05

Family

ID=40935525

Family Applications (1)

Application Number Title Priority Date Filing Date
SM201500086T SMT201500086B (it) 2009-04-20 2015-04-09 Uso del nifuratel per il trattamento di infezioni causate dalla specie atopobium

Country Status (26)

Country Link
US (1) US8673886B2 (xx)
EP (2) EP2243482A1 (xx)
JP (1) JP2012524117A (xx)
KR (1) KR101664889B1 (xx)
CN (1) CN102395367B (xx)
BR (1) BRPI1015089A2 (xx)
CA (1) CA2755328C (xx)
CL (1) CL2011002563A1 (xx)
CY (1) CY1116209T1 (xx)
DK (1) DK2421531T3 (xx)
EA (1) EA021557B1 (xx)
ES (1) ES2532863T3 (xx)
GE (1) GEP20135892B (xx)
HK (1) HK1161837A1 (xx)
HR (1) HRP20150306T1 (xx)
HU (1) HUE026188T2 (xx)
ME (1) ME02141B (xx)
MX (1) MX2011011050A (xx)
PL (1) PL2421531T3 (xx)
PT (1) PT2421531E (xx)
RS (1) RS53907B1 (xx)
SI (1) SI2421531T1 (xx)
SM (1) SMT201500086B (xx)
UA (1) UA107346C2 (xx)
WO (1) WO2010121980A1 (xx)
ZA (1) ZA201106701B (xx)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2491929A1 (en) 2011-02-22 2012-08-29 Polichem SA Use of Nifuratel to treat infections caused by Clostridium species
CN102512750A (zh) * 2011-12-27 2012-06-27 上海市计划生育科学研究所 包含克霉唑和硝夫太尔的阴道给药装置及其制备方法
EP2610253A1 (en) * 2011-12-27 2013-07-03 Polichem SA Nifuratel sulfoxide for use in the treatment of bacterial infections.
EP2662371A1 (en) * 2012-05-11 2013-11-13 Polichem SA (R)-Nifuratel and synthesis of (R) and (S)-Nifuratel
WO2014071198A1 (en) * 2012-11-01 2014-05-08 The University Of Chicago Antibiotic methods and compositions for bacteria infections
CN111557897B (zh) * 2020-07-07 2023-06-23 温州海鹤药业有限公司 一种含有硝呋太尔的药物组合物及其制备方法
CN112353772A (zh) * 2020-10-20 2021-02-12 北京诚济制药股份有限公司 一种硝呋太尔阴道片及其制备方法
CN112972418B (zh) * 2021-05-18 2021-08-27 北京金城泰尔制药有限公司 硝呋太尔制霉素阴道软胶囊及其制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2008775C (en) 1989-02-24 1998-12-22 Alberto Ferro Nail lacquer
US6416779B1 (en) * 1997-06-11 2002-07-09 Umd, Inc. Device and method for intravaginal or transvaginal treatment of fungal, bacterial, viral or parasitic infections
DE50300325D1 (de) * 2003-11-03 2005-03-31 Peter-Hansen Volkmann Vaginalpflegezusammensetzung
SE528382C2 (sv) * 2004-10-05 2006-10-31 Probi Ab Probiotiska lactobacillusstammar för förbättrad vaginal hälsa
US7619008B2 (en) * 2004-11-12 2009-11-17 Kimberly-Clark Worldwide, Inc. Xylitol for treatment of vaginal infections
EP1872775A1 (en) * 2006-06-29 2008-01-02 Polichem S.A. Use of a hydrophilic matrix comprising a polyacrylic acid derivative, a cellulose ether and a disintegrant for the manufacture of a medicament for treating female genital disorders
CN100479817C (zh) * 2006-11-24 2009-04-22 门俐俐 硝呋太尔用于制备治疗口腔厌氧菌感染的药物的用途
CN101199474A (zh) * 2007-11-23 2008-06-18 程雪翔 硝呋太尔凝胶及其制备方法

Also Published As

Publication number Publication date
JP2012524117A (ja) 2012-10-11
CY1116209T1 (el) 2017-02-08
EP2243482A1 (en) 2010-10-27
RS53907B1 (en) 2015-08-31
US20120035124A1 (en) 2012-02-09
ES2532863T3 (es) 2015-04-01
HUE026188T2 (hu) 2016-05-30
EA201171270A1 (ru) 2012-05-30
EP2421531A1 (en) 2012-02-29
HRP20150306T1 (hr) 2015-04-10
ZA201106701B (en) 2013-03-27
KR101664889B1 (ko) 2016-10-12
CN102395367A (zh) 2012-03-28
UA107346C2 (en) 2014-12-25
EP2421531B1 (en) 2015-02-25
KR20110139298A (ko) 2011-12-28
EA021557B1 (ru) 2015-07-30
CN102395367B (zh) 2014-01-29
PL2421531T3 (pl) 2015-07-31
MX2011011050A (es) 2011-11-02
WO2010121980A1 (en) 2010-10-28
PT2421531E (pt) 2015-06-29
CA2755328C (en) 2016-08-30
CA2755328A1 (en) 2010-10-28
ME02141B (me) 2015-10-20
HK1161837A1 (en) 2012-08-10
US8673886B2 (en) 2014-03-18
GEP20135892B (en) 2013-07-25
BRPI1015089A2 (pt) 2016-04-26
CL2011002563A1 (es) 2012-05-25
DK2421531T3 (en) 2015-03-23
SI2421531T1 (sl) 2015-05-29

Similar Documents

Publication Publication Date Title
SMT201500086B (it) Uso del nifuratel per il trattamento di infezioni causate dalla specie atopobium
SMT201600254B (it) Procedimento per la preparazione di idromagnesite
SMT201600008B (it) Composti di piridazinone
SMT201500148B (it) Composizioni per uso nel trattamento di infezioni virali
DK3251678T3 (da) Benzoxaborolderivater til behandling af bakterieinfektioner
SMAP200900085A (it) 3-imidazolil-indoli per il trattamento di malattieproliferative
SMT201500053B (it) 2-Amminobenzimidazol-5-carbossammidi come agenti nati-infiammatori
SMT201400008B (it) Uso di betanecolo per il trattamento di xerostomia
SMT201400056B (it) Analoghi carba-nucleosidici per trattamento antivirale
DK3590928T3 (da) Pyrimidinderivater til behandling af virusinfektioner
BR112012013260A2 (pt) dispositivo usado para o tratamento de rinite através de iluminação bioestimulativa
BR112013014943A2 (pt) compostos úteis para o tratamento de aids
IT1395596B1 (it) Procedimento per la preparazione di sitagliptin
SMT201500123B (it) Dosaggio unitario di apadenoson
DK2455064T3 (da) Indretning til behandling af periodontal sygdom
IT1403733B1 (it) Apparato per l'essiccazione di gas.
IT1403988B1 (it) Processo per la preparazione di agenti di contrasto.
CO6801770A2 (es) Uso de secnidazol en el tratamiento de infecciones dentales
SMT201500039B (it) Uso del nifuratel per il trattamento di infenzionicausate dalle specie di clostridium
IT1403982B1 (it) Dispositivo per il trattamento delle stenosi esofagee
IT1398032B1 (it) Transferrina per il trattamento di malattie autoimmuni.
IT1391776B1 (it) Procedimento per la preparazione di dexlansoprazolo
IT1398507B1 (it) Composizione per il trattamento di neuropatie
IT1403712B1 (it) Zavorra per lenza da pesca.
IT1398273B1 (it) Procedimento per la preparazione di 14-bromo daunomicina